Ayala Pharmaceuticals Inc (ADXS)

[ubmmg]

I beg to disagree. As of 1/31/18 (last 10Q filling) they has cash and cash equivalents close to $58MM. They got $18.8M via a secondary. With a cash burn of $20.5M per quarter, they should have about $60M as of 4/30/18 and close to $53M now. This would last for about 7.5 months, or approximately until Mid January ‘19. Do you want to see the run completely on empty tanks? It’s a rule of thumb any public company to have at least 6-months worth of cash. If lower, all warning signs would go off. Unless they expect an approval to come before December or sign a partner for cervical by then to load up coffers, then they can take a chance. Otherwise, the Wall Street will punish them severely.
Do you see flaws here?